Skip to content
Screener

C4 Therapeutics CCCC Q2 2025 earnings

Reported August 7, 2025 · Before market open

Revenue$6.5MMiss by $337.0K
EPS-$0.37Beat by $0.01
Revenue estimate$6.8M
EPS estimate-$0.38

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$4.8M
EPS estimate-$0.21

FAQ

When did C4 Therapeutics report Q2 2025 earnings?
C4 Therapeutics (CCCC) reported Q2 2025 earnings on August 7, 2025 before market open.
What were C4 Therapeutics's Q2 2025 revenue and EPS?
C4 Therapeutics reported revenue of $6.5M and eps of $-0.37 for Q2 2025.
Did C4 Therapeutics beat estimates in Q2 2025?
Revenue missed the consensus estimate of $6.8M by $337.0K. EPS beat the consensus estimate of $-0.38 by $0.01.
How did C4 Therapeutics's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 46.2% from $12.0M a year earlier and eps declined 42.3% from $-0.26.
Where can I find C4 Therapeutics's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-038576) and the 10-Q periodic report (0001628280-25-038587) directly on SEC EDGAR. The filing index links above go to sec.gov.